Follow the Anacor Pharmaceuticals, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 5 February 2016 (Attribution). Among the most active insiders: IPPOLITO VINCENT P. The full history is openly available.
21
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
14 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Anacor Pharmaceuticals, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for dermatological diseases. It is listed on NASDAQ under the ticker ANAC.